About
High Fidelity Orthopaedics
At High Fidelity Orthopaedics, our team of engineering and medical professionals is dedicated to offering affordable personalized care and cutting-edge treatments. With over 40 years of iterative in-surgery development, our implant designs ensure consistency, compatibility, safety, and reliability for both surgeons and patients. We seamlessly integrate AI-enhanced workflows, real-time design of patient-matched medical devices, and on-demand production to revolutionize orthopaedic care.
OUR TEAM
Philip Crealy
Philip Crealy is a business leader and investor with a track record of successfully funding, developing, and commercialising high-growth medical technology and pharmaceutical ventures. With over 20 years of experience in the life sciences sector, he has been directly responsible for securing regulatory approvals and driving on-market sales for more than 200 medical devices and 30 pharmaceutical products.
As the Founder and Director of Equinox Medical, High Fidelity Orthopaedics, and Centralyze, Philip has led the commercialisation of cutting-edge medical devices and biopharmaceutical innovations. His leadership has focused on delivering market-leading and cost-effective products and services in pathology and orthopaedics and investing returns on Australian-led innovation.
Since 2016, Philip has led Centralyze, a biomedical accelerator and investment collective. Centralyze supports the development and commercial scaling of Australian pharmaceutical and medical device technologies onto the global stage. He has played a pivotal role in building high-performing commercial and clinical teams, securing investment, and accelerating companies from R&D to successful market entry.
Philip has a deep expertise in regulatory and reimbursement, and is actively involved in policy discussion and clinical data generation in the growing space of personalised medical devices. He has worked alongside government and regulatory bodies to refine frameworks that support innovation while ensuring patient safety and commercial viability.
Earlier in his career, Philip held medical affairs and business development roles at Sanofi, Merck, Allergan (AbbVie), and AstraZeneca, where he supported the market entry and launch of new therapeutics and devices, in addition to ongoing product lifecycle management, pricing strategy, and market access activities.
Beyond his commercial ventures, Philip is committed to fostering industry collaboration and mentoring the next generation of biotech entrepreneurs. Through his work with academics and researchers within universities and incubators across the life-science ecosystem. His life-goal is to support the development of innovative and affordable medical technologies that improve patient outcomes and expand access to healthcare.
Chris Wilson
Chris Wilson is a highly driven leader within the medical device industry, with over 20 years of experience working in the Australian healthcare and Medtech sectors.
Chris has a background in Exercise Physiology, conducting research into the effects of exercise on insulin signalling pathways at Deakin University and working directly with clients.
He previously worked in the pharmaceutical industry, focussing on diabetes treatment, and is a founding board member of Alfie Therapeutics, a leading plant-based medicine provider.
For the last 15 years, Orthopaedic trauma has been Chris’ specialty focus. Throughout a career at Stryker, a leading global device manufacturer, Chris built and led several high performing teams across sales and marketing, achieving sustained market share growth and launching leading products and programs.
Chris is passionate about developing deep customer insights that help guide effective strategy. Through extensive experience developing, integrating and executing these strategies, as well as coaching and mentoring other leaders, Chris has gained a unique perspective on the Australian orthopaedic trauma market.
In his current role as CEO of HiFi-Ortho, Chris is driven to help re-define the standard of care for orthopaedic trauma patients by delivering enabling technology and enhanced value to hospitals, surgeons and most importantly, to the patients they treat.
A/Prof Mohammad Saadatfar
Associate Professor Mohammad Saadatfar is a distinguished physicist and researcher based at the Australian National University (ANU) and the University of Sydney (USYD). He holds a PhD in Physics and is a prominent figure in the field of materials physics, particularly known for his work on granular materials and X-ray tomography.
Dr. Saadatfar completed his advanced training at ANU, where he has been involved in numerous research projects focusing on the geometrical structure and mechanical behavior of disordered sphere packings, porosity characterization of coal, and the onset of mechanical stability in random packings of frictional spheres. His research has been widely recognized and cited in various scientific journals.
As a senior researcher, Dr. Saadatfar has collaborated with international experts and contributed to significant advancements in the understanding of granular materials. His work has applications in diverse fields, including geology, materials science, and engineering.
Dr. Saadatfar’s clinical interests include the application of micro-CT imaging technology to study the microstructure of materials, such as wood used in cricket bats and closed-cell aluminum foams under impact conditions. He is committed to advancing scientific knowledge and contributing to the development of new technologies with real-world applications in medicine.
Dr. Saadatfar has also focused on medical applications, utilising his expertise in the geometrical structure of metals and advanced imaging in the development of customized bone plates using AI/ML driven 3D data processing. His technology has previously been acquired by Thermo Fisher Scientific, and utilised in their Brain Software, Amira, for advanced 3D visualization and analysis.
Dr Tom Ward
Dr. Tom Ward is a highly accomplished orthopaedic surgeon based in Canberra, Australia. He is a Fellow of the Royal Australasian College of Surgeons (FRACS) and the Australian Orthopaedic Association (FAOrthA), and holds a Doctor of Philosophy (D.Phil) from the University of Oxford. Dr. Ward is triple fellowship trained, with subspecialty expertise in robotic knee, hip, and trauma surgery.
Dr. Ward completed his advanced training at the world-renowned Nuffield Orthopaedic Centre, Oxford University Hospitals, and in Canberra. He holds top honours degrees in medicine from the Australian National University (ANU) and in engineering from Queensland University of Technology (QUT), both with a university medal. He was additionally named Queensland’s Rhodes Scholar in 2001. His research at Oxford focused on knee replacement, and he has been recognized for his contributions to the field.
As a Rhodes Scholar, Dr. Ward has demonstrated exceptional academic and professional achievements. In addition to his clinical work, Dr. Ward is passionate about improving prosthetics and orthotics training in Cambodia and has consulted internationally for McKinsey and Company in the USA and the Middle East. As a senior lecturer at ANU’s medical school, his ongoing research focuses on enhancing the movement of knee and hip joints and innovations using 3D printing and robotics in orthopaedic surgery.
Dr. Ward’s clinical interests include hip and knee replacement surgery, hip and knee arthroscopy, knee ligament surgery, and trauma surgery. In particular, given his strong interest in complex pelvic fractures, Dr Ward recognises the challenge but also opportunity in delivering patient-matched custom orthopaedic implants in the emergency trauma setting.